Coverage
-
November 06, 2026
A Connecticut federal judge has granted final approval to a $29.6 million settlement between dozens of states and Glenmark Pharmaceuticals that resolves claims accusing the company of conspiring with competitors to drive up drug prices.
69 other articles on this case.
View all »